The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...
Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
Investing.com -- Pfizer Inc. (NYSE: PFE) stock fell 1.5% following reports that U.S. prosecutors are investigating a claim ...
A senior GSK scientist, who formerly worked at rival Pfizer, had told GSK colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until after that year’s election.
US Prosecutors Probe Tip About Timing of Pfizer's COVID Vaccine, WSJ Reports (Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...
The report said on Wednesday GSK's former head of vaccine development, Philip Dormitzer, had told his colleagues about the delay by Pfizer, where he worked before joining the British company.